Deletion of miR-150 Prevents Spontaneous T Cell Proliferation and the Development of Colitis

Sayaka Ishihara1,2, Masashi Sato3, Haruka Miyazaki1

  • 1Department of Biosciences, School of Science, Kitasato University, Sagamihara, Kanagawa, Japan.

Gastro Hep Advances
|August 12, 2024
PubMed
Abstract

Insights

MicroRNA-150 (miR-150) promotes colitis by increasing pathogenic T helper 17 cells. Inhibiting miR-150 effectively prevents colitis development, highlighting its therapeutic potential for inflammatory bowel diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Gastroenterology

Background:

  • MicroRNAs play crucial roles in immune system regulation.
  • Colitis is characterized by inflammation of the colon, often involving T cell dysregulation.
  • Increased expression of miR-150 was observed in colitogenic CD4+ T cells.

Purpose of the Study:

  • To investigate the role of microRNA-150 (miR-150) in the pathogenesis of colitis.
  • To determine the impact of miR-150 on T cell responses in colitis models.

Main Methods:

  • RNA sequencing was performed on normal and colitogenic CD4+ T cells.
  • miR-150 knockout mice and T-cell-specific Rap1KO mice were utilized as colitis models.
  • The effect of miR-150 silencing on T cell expansion and colitis development was assessed.

Main Results:

  • Colitogenic CD4+ T cells exhibited significantly higher miR-150 expression.
  • Silencing miR-150 completely prevented the expansion of pathogenic Th17 cells.
  • Inhibition of miR-150 led to the complete suppression of colitis development.

Conclusions:

  • miR-150 is a key mediator in the development of colitis.
  • Targeting miR-150 presents a promising therapeutic strategy for inflammatory bowel diseases.
  • Further research into miR-150's mechanisms could lead to novel treatments for IBD.